Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
The recombination immunity toxin which makes meso Terin a target
Document Type and Number:
Japanese Patent JP6169561
Kind Code:
B2
Abstract:
Mesothelin is a differentiation antigen present on the surface of ovarian cancers, mesotheliomas and several other types of human cancers. Because among normal tissues, mesothelin is only present on mesothelial cells, it represents a good target for antibody mediated delivery of cytotoxic agents. The present invention is directed to improved recombinant immunotoxins comprising anti-mesothelin antibodies, including Fv molecules with particularly high affinity for mesothelin, and a Pseudomonas Exotoxin moiety which has been modified to reduce its immunogenicity and protease sensitivity and providing a better cytotoxicity for cells which express mesothelin. The RITs are well-suited for the treatment of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin.

Inventors:
Pastan, Illa H.
Weldon, john
Beards, Richard
Application Number:
JP2014509467A
Publication Date:
July 26, 2017
Filing Date:
May 04, 2012
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Man Services
International Classes:
C12N15/09; A61K39/395; A61P35/00; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10
Domestic Patent References:
JP2008523105A
JP2008526889A
JP2009514537A
Foreign References:
WO2009032954A1
WO2011032022A1
Attorney, Agent or Firm:
Sonoda/Kobayashi Patent Business Corporation